TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Alexion Pharma Nordics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,663
|
24,272
|
23,504 |
| Financial expenses |
23
|
162
|
4 |
| Earnings before taxes |
553
|
1,123
|
700 |
| EBITDA |
409
|
1,111
|
654 |
| Total assets |
8,264
|
15,909
|
9,673 |
| Current assets |
8,180
|
15,909
|
9,673 |
| Current liabilities |
5,740
|
10,985
|
5,546 |
| Equity capital |
2,523
|
4,923
|
4,126 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
16
|
14
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
30.5%
|
30.9%
|
42.7% |
| Turnover per employee |
354
|
1,734
|
1,567 |
| Profit as a percentage of turnover |
9.8%
|
4.6%
|
3.0% |
| Return on assets (ROA) |
7.0%
|
8.1%
|
7.3% |
| Current ratio |
142.5%
|
144.8%
|
174.4% |
| Return on equity (ROE) |
21.9%
|
22.8%
|
17.0% |
| Change turnover |
-17,784
|
700
|
2,462 |
| Change turnover % |
-76%
|
3%
|
12% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
14%
|
-7%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.